Concepedia

Silvia Buonamici

SB

57

Publications

9.3K

Citations

40

H-Index

2000

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Dana-Farber Cancer Institute

Harvard University

New York University

University of Illinois Chicago

Silvia Buonamici is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, cell biology, and cancer research.

Top concepts

MedicineCell BiologyCancer ResearchImmunologyTumor BiologyRadiation OncologyPathologyHematologyOncologyCancer Biology

Publications per year

2000–2024

57

Publications

57

The allosteric inhibitor ABL001 enables dual targeting of BCR–ABL1

Andrew A. Wylie, Joseph Schoepfer, Wolfgang Jahnke et al. · Nature · 2017 · 574 citations

Molecular Pharmacology, Drug Target, Medicine +3

SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition

Eun Hee Kim, Janine O. Ilagan, Yang Liang et al. · Cancer Cell · 2015 · 558 citations · Full text

Genome Instability, Somatic Variant, Genetics +8

Interfering with Resistance to Smoothened Antagonists by Inhibition of the PI3K Pathway in Medulloblastoma

Silvia Buonamici, Juliet Williams, Michael Morrissey et al. · Science Translational Medicine · 2010 · 553 citations

H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers

Michael Seiler, Akihide Yoshimi, Rachel Darman et al. · Nature Medicine · 2018 · 491 citations · Full text

Tumor Biology, Medicine, Rna Splicing +9

The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia

Benjamin J. Thompson, Silvia Buonamici, Maria Luisa Sulis et al. · The Journal of Experimental Medicine · 2007 · 485 citations · Full text

Rows per page

1–5 of 57